GUSELKUMAB INDUCTION RESTORES INTESTINAL IMMUNE HOMEOSTASIS AND PROMOTES EPITHELIAL REPAIR IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

被引：0
|
作者：
Sridhar, Sunan
Hart, Amy
Venkat, Swati
Ruane, Darren
Horowitz, Dan
Lee, Tae
Waterworth, Dawn M.
Huang, Kuan-Hsiang G.
Germinaro, Matthew
Vetter, Marion
Cua, Daniel
Freeman, Tom C.
Sisk, Christopher
Mcrae, Bradford
Verstockt, Bram
Rubin, David T.
Sands, Bruce E.
Branigan, Patrick
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1732
引用
收藏
页码：S790 / S790
页数：1
相关论文
共 50 条
  • [1] Guselkumab induction restores intestinal immune homeostasis and promotes epithelial repair in moderately to severely active Ulcerative Colitis
    Sridhar, S.
    Hart, A.
    Venkat, S.
    Ruane, D.
    Horowitz, D.
    Lee, T.
    Waterworth, D.
    Huang, K. H. G.
    Germinaro, M.
    Vetter, M.
    Cua, D.
    Freeman, T. C.
    Sisk, C.
    McRae, B.
    Verstockt, B.
    Rubin, D. T.
    Sands, B. E.
    Branigan, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I41 - I41
  • [2] Guselkumab for moderately to severely active ulcerative colitis
    不详
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (02): : 112 - 112
  • [3] QUASAR Induction Study 1 Cumulative Response to Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis
    Peyrin-Biroulet, L.
    Rubin, D.
    Lichtenstein, G.
    Shipitofsky, N.
    Huang, K. H.
    Germinaro, M.
    Wilson, R.
    Zhang, H.
    DuVall, G. A.
    Cao, Q.
    Allegretti, J.
    Feagan, B.
    Hisamatsu, T.
    Panes, J.
    Dignass, A.
    Bressler, B.
    Sands, B.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 624 - 625
  • [4] QUASAR Induction Study 1 Cumulative Response to Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis
    Sands, Bruce E.
    Rubin, David T.
    Lichtenstein, Gary
    Shipitofsky, Nicole
    Huang, Kuan-Hsiang
    Germinaro, Matthew
    Wilson, Rebbecca
    Zhang, Hongyan
    DuVall, Aaron
    Cao, Qian
    Allegretti, Jessica R.
    Feagan, Brian G.
    Peyrin-Biroulet, Laurent
    Hisamatsu, Tadakazu
    Panes, Julian
    Dignass, Axel
    Bressler, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S526 - S527
  • [5] Guselkumab: A New Therapeutic Option for the Treatment of Moderately to Severely Active Ulcerative Colitis
    Bhat, Shubha
    Choi, David
    ANNALS OF PHARMACOTHERAPY, 2025,
  • [6] Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
    Peyrin-Biroulet, Laurent
    Allegretti, Jessica R.
    Rubin, David T.
    Bressler, Brian
    Germinaro, Matthew
    Huang, Kuan-Hsiang
    Shipitofsky, Nicole
    Zhang, Hongyan
    Wilson, Rebbecca
    Han, Chenglong
    Feagan, Brian G.
    Sandborn, William J.
    Panes, Julian
    Hisamatsu, Tadakazu
    Lichtenstein, Gary R.
    Sands, Bruce E.
    Dignass, Axel
    GASTROENTEROLOGY, 2023, 165 (06) : 1443 - 1457
  • [7] Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis
    Ignacio Fernandez-Blanco, J.
    Fernandez-Diaz, Guillermo
    Cara, Carlos
    Vera, Maria I.
    Olivares, David
    Taxonera, Carlos
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) : 731 - 737
  • [8] Adalimumab for Induction of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
    Reinisch, Walter
    Sandborn, William J.
    Hommes, Daniel W.
    D'Haens, Geert R.
    Hanauer, Stephen B.
    Schreiber, Stefan
    Panaccione, Remo
    Fedorak, Richard N.
    Tighe, Mary Beth
    Huang, Bidan
    Lazar, Andreas
    GASTROENTEROLOGY, 2010, 138 (05) : S114 - S115
  • [9] Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis
    J. Ignacio Fernández-Blanco
    Guillermo Fernández-Díaz
    Carlos Cara
    María I. Vera
    David Olivares
    Carlos Taxonera
    Digestive Diseases and Sciences, 2018, 63 : 731 - 737
  • [10] Golimumab for moderately to severely active ulcerative colitis
    Kedia, Saurabh
    Ahuja, Vineet
    Makharia, Govind K.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (10) : 1273 - 1282
12345